drugset
Drugs / Allogeneic adipose tissue-derived mesenchymal stem cells
last change Dec 2025 re-read 3 minutes ago

Allogeneic adipose tissue-derived mesenchymal stem cells

Cell therapy

Developed for
abdominal aortic aneurysm · ulcerative colitis
Investigated by
Instituto de Investigación Hospital Universitario La Paz · Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz · Grupo Dermatologico Y Estetico Pedro Jaen S.A. · Ministry of Health, Spain

Trials 2

today NCT06488898 · Ph 2 NCT01914887 · Ph 1/2
20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/21 trial
Phase 1/2 NCT01914887 Jun → Dec 2013 ulcerative colitis Instituto de Investigación Hospital Universitario La Paz Unknown No outcome recorded
Phase 21 trial
Phase 2 NCT06488898 Jun 2024 → Dec 2025 abdominal aortic aneurysm Instituto de Investigación Hospital Universitario La Paz Unknown No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Allogeneic adipose tissue-derived mesenchymal stem cells ClinicalTrials.gov intervention name — accepted as the source's own label NCT06488898 ↗
1

NCT01914887 ↗
Modality Cell therapy “adipose tissue-derived mesenchymal stem cells” NCT01914887 ↗
Route Other “intracolonic injection” NCT01914887 ↗